Showing results (11-20 of 34) with videos related to
Sort By:
Pageof 4
Current Medicinal Chemistry|March 28, 2013
MEK inhibition increases lapatinib sensitivity via modulation of FOXM1S S Gayle, R C Castellino, M C Buss, et al.American Journal of Hematology|February 1, 1996
Allogeneic bone marrow transplantation in a patient with hypereosinophilic syndromeF J Esteva-Lorenzo, K R Meehan, T R Spitzer, et al.Cancer Treatment Reviews|November 2, 1999
Chemo-signal therapy, an emerging new approach to modify drug resistance in breast cancerL Pusztai, F J Esteva, M Cristofanilli, et al.Current Medicinal Chemistry|November 21, 2013
P38 MAPK contributes to resistance and invasiveness of HER2- overexpressing breast cancerS M Donnelly, E Paplomata, B M Peake, et al.The Oncologist|April 18, 2001
Chemotherapy of metastatic breast cancer: what to expect in 2001 and beyondF J Esteva, V Valero, L Pusztai, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2011
Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancerX He, F J Esteva, J Ensor, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2001
Safety and efficacy of bisphosphonates beyond 24 months in cancer patientsS M Ali, F J Esteva, G Hortobagyi, et al.Skeletal Radiology|October 1, 1994
Case report 866. Pseudotumor of the muscle associated with necrotizing vasculitis of medium- and small-sized arteries and chronic myositisF J Esteva-Lorenzo, J L Ferreiro, F Tardaguila, et al.Oncogene|December 1, 2009
Calpain regulates sensitivity to trastuzumab and survival in HER2-positive breast cancerS Kulkarni, K B Reddy, F J Esteva, et al.Cancer|October 1, 1995
Myositis associated with interleukin-2 therapy in a patient with metastatic renal cell carcinomaF J Esteva-Lorenzo, J E Janik, R G Fenton, et al.Pageof 4